The leading player in targeted oral dose Gut Microbiome Antibodies since 2007
We are developing oral antibody therapy solutions, with positive proof of concept results for C Difficile infection (now in phase 2 clinical trial), Traveler’s Diarrhea, Obesity, Acid Reflux, Arthritis, Asthma and IBS. Other potential targets include IBD, Covid-19, UTI, Stress, Anxiety, Depression, Heart Disease, Colorectal cancer, Alzheimer’s, Parkinson’s, Autism and many more. Not to mention Pet and Animal Health treatments as well as Environmental and Humanitarian opportunities.
Our Antibodies represent a very different Pharma medicine proposal. Like other Pharma’s we are developing Biologic treatments to various targeted diseases. Unlike other Pharma’s, we are doing this using a very safe and effective whole food substrate delivery system.
Our treatments can be targeted as per our C Difficile Antibodies (C DIFF FYX) to eliminate this bacterial infection, or be more general as per our GUT FYX / ImmunAde Oral Antibodies taken daily to provide an extra serving of natural immunity, helping your Immune System keep Microbiome Dysbiosis in check and therefore maintain bacterial diversity, which correlates with good health.
As the World’s first oral dosed Antibody Therapy (CFIA registered Hyper-Egg K88 to treat E Coli infection in food production animals, 2007), our Antibodies are a Safe, Effective and Affordable way of treating enteric infections and other health disorders.
J. H. Hare & Associates Ltd., was incorporated in Manitoba, Canada in 1970, by Dr. J. H. Hare.
John S Hare acquired this company in 1987.
About Us
We are the leading player in targeted oral dose Gut Microbiome Antibodies since 2007
In 2007, we registered the World’s first oral antibody Animal health treatment, with the claim to “Aid in the prevention of diarrhea caused by E. coli bacteria”. This product has been sold in various countries around the world.
Our Antibodies represent a very different Pharma medicine proposal. Like other Pharma’s we are developing Biologic treatments to various targeted diseases. Unlike other Pharma’s, we are doing this using a very safe and effective whole food substrate delivery system.
Solving problems since 1979
helping your Immune System keep Microbiome Dysbiosis in check
Why choose us
The First In the World oral dose antibodies
Natural Food Antibodies
A Daily Serving of Natural IgY Antibodies Addressing Gut Microbiome and Immune System Deficiencies
Healing & Infection blocking antibodies
Proposed COVID-19 Treatment (COVID FYX)
Pipeline Health Treatments
HAREMAN Humanitarian
IMMUNIMED Inc., Clinical Stage Biopharmaceuticle company.
C Difficile Antibody treatment (C DIFF FYX)
Animal Health
Hyper-Egg Veterinary Biologics